Sign In
Buy GH
$127.03
-3.14 (-2.41%)
At Close: Jun 03, 2026
Like Guardant Health? You'll Love CareDx
08:17am, Wednesday, 03'rd Mar 2021
This under-the-radar diagnostics company is thriving yet reasonably priced.
Guardant360® CDx Liquid Biopsy CE-Marked for Comprehensive Tumor Mutation Profiling Across All Solid Cancers
08:05am, Tuesday, 02'nd Mar 2021
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH) has CE-marked Guardant360® CDx for tumor mutation profiling, also known as comprehensive genomic profiling (CGP), in patients
Why Guardant Health Stock Is Sinking Today
11:34am, Thursday, 25'th Feb 2021
The company reported disappointing Q4 results.
What's Behind Guardant Health's Disappointing Q4 Results
06:04am, Thursday, 25'th Feb 2021
The company beat revenue expectations, but its bottom-line performance and 2021 outlook weren't what investors hoped for.
Guardant Health, Inc. (GH) CEO Helmy Eltoukhy on Q4 2020 Results - Earnings Call Transcript
12:46am, Thursday, 25'th Feb 2021
Guardant Health, Inc. (GH) CEO Helmy Eltoukhy on Q4 2020 Results - Earnings Call Transcript
Guardant Health Earnings Preview
10:24am, Tuesday, 23'rd Feb 2021
On Wednesday, February 24, Guardant Health (NASDAQ:GH) will release its latest earnings report. Benzinga's report can help you figure out the ins and outs of the earnings release.
Adding $5,000 to These 2 Top Stocks Could Make You Richer in 2021 (and Beyond)
06:17am, Sunday, 21'st Feb 2021
These two companies have exciting long-term prospects.
2 Fantastic Growth Stocks to Buy Right Now
06:12am, Sunday, 21'st Feb 2021
This cannabis producer and liquid biopsy pioneer should make investors a lot of money.
Analysts Estimate Guardant Health (GH) to Report a Decline in Earnings: What to Look Out for
01:40pm, Wednesday, 17'th Feb 2021
Guardant Health (GH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, announced the availability of Guardant Reveal™, the first blood-only liquid biopsy te
3 Revolutionary Stocks That Can Make You Rich
06:01am, Friday, 12'th Feb 2021
Here's why they're such great picks.
3 Companies With High Quality Balance Sheets to Consider
12:22pm, Wednesday, 10'th Feb 2021
If you screen the market for stocks that have a current ratio higher than 2 and more working capital than long-term debt, as Benjamin Graham, the pioneer of value investing, recommended, the chances t
3 No-Brainer Stocks to Buy That Should Soar This Year
05:52am, Friday, 05'th Feb 2021
Each of them has clear potential catalysts ahead.
Ignore GameStop: Here Are 3 Better Stocks
06:10am, Wednesday, 03'rd Feb 2021
Don't get caught chasing the hype.
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH). Despite guideline recommendations for comprehensive genomic profiling (CGP) of all patients with advanced non-small cell lung
